Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,626 | 7,509 | 34,590 | 46,885 | -72,700 |
| Depreciation Amortization | 8,356 | 6,268 | 4,173 | 2,048 | 8,121 |
| Accounts receivable | -7,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -13,708 | -3,096 | -11,976 | -10,874 | 6,252 |
| Other Working Capital | -9,189 | -5,826 | -127,342 | -98,635 | 91,397 |
| Other Operating Activity | 37,369 | 15,361 | 20,343 | 15,084 | 8,926 |
| Operating Cash Flow | $-22,798 | $20,216 | $-80,212 | $-45,492 | $41,996 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -97,133 | -32,834 | -71,623 | -98,642 | -40,464 |
| PPE Investments | -4,700 | -3,933 | -3,282 | -1,587 | -3,988 |
| Investing Cash Flow | $-101,833 | $-36,767 | $-74,905 | $-100,229 | $-44,452 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,708 | 727 | 379 | 14 | 52,532 |
| Other Financing Activity | -357 | 0 | 0 | 0 | 46,360 |
| Financing Cash Flow | $30,351 | $727 | $379 | $14 | $98,892 |
| Beginning Cash Position | 229,117 | 229,117 | 229,117 | 229,117 | 132,681 |
| End Cash Position | 134,837 | 213,293 | 74,379 | 83,410 | 229,117 |
| Net Cash Flow | $-94,280 | $-15,824 | $-154,738 | $-145,707 | $96,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,798 | 20,216 | -80,212 | -45,492 | 41,996 |
| Capital Expenditure | -4,700 | -3,933 | -3,282 | -1,587 | -3,988 |
| Free Cash Flow | -27,498 | 16,283 | -83,494 | -47,079 | 38,008 |